Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


All chapters
Previous chapter Next chapter

Chapter 15

Organoselenium Compounds as Cancer Therapeutic Agents

Selenium (Se) is an essential trace element involved in many fundamental biological processes. Our knowledge about the potential of Se in cancer therapy has expanded greatly in recent years and has opened a new research perspective in the development of selenium-based anticancer agents. Notably, selenium compounds possess a selective activity against tumor cells, and the major mechanisms accounting for this selectivity are the tumor-specific Se uptake and the dysregulation of redox homeostasis in cancer cells. Herein, we summarize the current knowledge on organoselenium compounds endowed with in vitro and/or in vivo antitumor potential.

Publication details


Print publication date
03 Oct 2017
Copyright year
2018
Print ISBN
978-1-78801-029-0
PDF eISBN
978-1-78801-190-7
ePub eISBN
978-1-78801-223-2